Hybrid Imaging Consulting offers specialized services for optimal utilization of imaging technology in preclinical studies, specifically molecular and hybrid imaging, improving research accuracy and advancing drug development.




– Access to clinical hybrid imaging modalities (upon approval by Rad/Nuc)
– Access to pre-clinical hybrid imaging modalities (dito, PIL)
– Quantification pipelines for PET imaging in context of PET/CT and PET/MR
– Expertise in standardized and harmonized imaging protocols (mainly PET)
– Guidance to high-quality and low-frequency of artifacts imaging


– Methodological support for full quantification of PET-based biomarkers, incl. corrections for partial volume, positron range and subject motion
– Design of multi-parametric image quality phantoms
– Machine learning based prediction models for tumour phenotyping

Check out our Instagram profile and follow us for bursts of inspiration.